Approval · Notice of Compliance 7370 · 2005
HALOPERIDOL INJECTION USP: Notice of Compliance 7370
Issued September 14, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7370
- Date
- September 14, 2005
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antipsychotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION USP | 00808652 | Marketed |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML